Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CLEOCIN

CLINDAMYCIN PALMITATE HYDROCHLORIDE

Standard Dose
EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CLEOCIN is listed in Drugs@FDA under application 061827 (ANDA).

Marketing status: Discontinued Active ingredient CLINDAMYCIN PALMITATE HYDROCHLORIDE Form and strength FOR SOLUTION;ORAL - EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CLEOCIN is listed in Drugs@FDA under application 061827 (ANDA). Marketing status: Discontinued Active ingredient CLINDAMYCIN PALMITATE HYDROCHLORIDE Form and strength FOR SOLUTION;ORAL - EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.